Trishna Goswami - Oct 21, 2022 Form 4 Insider Report for IN8BIO, INC. (INAB)

Role
Chief Medical Officer
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
INAB
Transactions as of
Oct 21, 2022
Transactions value $
$0
Form type
4
Date filed
10/25/2022, 04:32 PM
Previous filing
Aug 18, 2022
Next filing
Apr 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INAB Employee Stock Option (right to buy) Award $0 +68.4K $0.00 68.4K Oct 21, 2022 Common Stock 68.4K $1.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in three equal annual installments commencing on October 21, 2024, subject to the Reporting Person continuing to provide service through each such date.